Cognitive Performance in Methadone Maintenance Patients: Effects of Time Relative to Dosing and Maintenance Dose Level

Given the long-term nature of methadone maintenance treatment, it is important to assess the extent of cognitive side effects. This study investigated cognitive and psychomotor performance in 51 methadone maintenance patients (MMP) as a function of time since last methadone dose and maintenance dose...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental and clinical psychopharmacology 2014-06, Vol.22 (3), p.248-256
Hauptverfasser: Rass, Olga, Kleykamp, Bethea A, Vandrey, Ryan G, Bigelow, George E, Leoutsakos, Jeannie-Marie, Stitzer, Maxine L, Strain, Eric C, Copersino, Marc L, Mintzer, Miriam Z
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 256
container_issue 3
container_start_page 248
container_title Experimental and clinical psychopharmacology
container_volume 22
creator Rass, Olga
Kleykamp, Bethea A
Vandrey, Ryan G
Bigelow, George E
Leoutsakos, Jeannie-Marie
Stitzer, Maxine L
Strain, Eric C
Copersino, Marc L
Mintzer, Miriam Z
description Given the long-term nature of methadone maintenance treatment, it is important to assess the extent of cognitive side effects. This study investigated cognitive and psychomotor performance in 51 methadone maintenance patients (MMP) as a function of time since last methadone dose and maintenance dose level. MMP maintained on doses ranging from 40 to 200 mg (mean = 97 mg) completed a battery of psychomotor and cognitive measures across 2 sessions, during peak and trough states, in a double-blind crossover design. Peak sessions were associated with worse performance on measures of sensory processing, psychomotor speed, divided attention, and working memory, compared with trough sessions. The effects of maintenance dose were mixed, with higher dose resulting in worse performance on aspects of attention and working memory, improved performance on executive function, and no effects on several measures. Longer treatment duration was associated with better performance on some measures, but was also associated with increased sensitivity to time since last dose (i.e., worse performance at peak vs. trough) on some measures. The results suggest that cognitive functioning can fluctuate as a function of time since last dose even in MMP who have been maintained on stable doses for an extended time (mean duration in treatment = 4 years), but worsened performance at peak is limited to a subset of functions and may not be clinically significant at these modest levels of behavioral effect. For patients on stable methadone maintenance doses, maintenance at higher doses may not significantly increase the risk of performance impairment.
doi_str_mv 10.1037/a0035712
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4041803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1501369449</sourcerecordid><originalsourceid>FETCH-LOGICAL-a436t-791756d8af3913b0b265e50955a92dede2349bc57d3b2e44afa242a76581cbe03</originalsourceid><addsrcrecordid>eNpVkVtr3DAQhUVpaS4t9BcUQV8KwY2uttWHQtmmTWBDQ0mfxdge7yp4JUfSLuTfV80mIXmaYeabMwcOIR84-8KZbE6BMakbLl6RQ25kXQlh5OvSs1pVXJjmgByldMMYV9KIt-RAKK1aodQh2S3CyrvsdkivMI4hbsD3SJ2nl5jXMASP9BKcz-jvF1eQHfqcvtKzccQ-JxpGeu02SP_gBPc6OdAfITm_ouCHF8dljHSJO5zekTcjTAnfP9Rj8vfn2fXivFr-_nWx-L6sQMk6V43hja6HFkZpuOxYJ2qNmhmtwYgBBxRSma7XzSA7gUrBCEIJaGrd8r5DJo_Jt73uvO02OPTFeoTJztFtIN7ZAM6-3Hi3tquws4op3jJZBD49CMRwu8WU7U3YRl88W64Zl7VRyhTq857qY0gp4vj0gTP7PyH7mFBBPz539AQ-RlKAkz0AM9g53fUQs-snTP02xuLSzmuwQlhZTlr5D5xqm7w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1501369449</pqid></control><display><type>article</type><title>Cognitive Performance in Methadone Maintenance Patients: Effects of Time Relative to Dosing and Maintenance Dose Level</title><source>MEDLINE</source><source>EBSCOhost APA PsycARTICLES</source><creator>Rass, Olga ; Kleykamp, Bethea A ; Vandrey, Ryan G ; Bigelow, George E ; Leoutsakos, Jeannie-Marie ; Stitzer, Maxine L ; Strain, Eric C ; Copersino, Marc L ; Mintzer, Miriam Z</creator><contributor>Evans, Suzette M</contributor><creatorcontrib>Rass, Olga ; Kleykamp, Bethea A ; Vandrey, Ryan G ; Bigelow, George E ; Leoutsakos, Jeannie-Marie ; Stitzer, Maxine L ; Strain, Eric C ; Copersino, Marc L ; Mintzer, Miriam Z ; Evans, Suzette M</creatorcontrib><description>Given the long-term nature of methadone maintenance treatment, it is important to assess the extent of cognitive side effects. This study investigated cognitive and psychomotor performance in 51 methadone maintenance patients (MMP) as a function of time since last methadone dose and maintenance dose level. MMP maintained on doses ranging from 40 to 200 mg (mean = 97 mg) completed a battery of psychomotor and cognitive measures across 2 sessions, during peak and trough states, in a double-blind crossover design. Peak sessions were associated with worse performance on measures of sensory processing, psychomotor speed, divided attention, and working memory, compared with trough sessions. The effects of maintenance dose were mixed, with higher dose resulting in worse performance on aspects of attention and working memory, improved performance on executive function, and no effects on several measures. Longer treatment duration was associated with better performance on some measures, but was also associated with increased sensitivity to time since last dose (i.e., worse performance at peak vs. trough) on some measures. The results suggest that cognitive functioning can fluctuate as a function of time since last dose even in MMP who have been maintained on stable doses for an extended time (mean duration in treatment = 4 years), but worsened performance at peak is limited to a subset of functions and may not be clinically significant at these modest levels of behavioral effect. For patients on stable methadone maintenance doses, maintenance at higher doses may not significantly increase the risk of performance impairment.</description><identifier>ISSN: 1064-1297</identifier><identifier>EISSN: 1936-2293</identifier><identifier>DOI: 10.1037/a0035712</identifier><identifier>PMID: 24548244</identifier><language>eng</language><publisher>United States: American Psychological Association</publisher><subject>Adult ; Cognition - drug effects ; Cognition - physiology ; Cognitive Ability ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug Abuse ; Drug Dosages ; Drug Therapy ; Female ; Human ; Humans ; Male ; Methadone - administration &amp; dosage ; Methadone Maintenance ; Middle Aged ; Opiate Substitution Treatment - methods ; Outpatient ; Psychomotor Performance - drug effects ; Psychomotor Performance - physiology ; Reaction Time - drug effects ; Reaction Time - physiology ; Side Effects (Drug)</subject><ispartof>Experimental and clinical psychopharmacology, 2014-06, Vol.22 (3), p.248-256</ispartof><rights>2014 American Psychological Association</rights><rights>PsycINFO Database Record (c) 2014 APA, all rights reserved.</rights><rights>2014, American Psychological Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a436t-791756d8af3913b0b265e50955a92dede2349bc57d3b2e44afa242a76581cbe03</citedby><orcidid>0000-0002-6651-7358</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24548244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Evans, Suzette M</contributor><creatorcontrib>Rass, Olga</creatorcontrib><creatorcontrib>Kleykamp, Bethea A</creatorcontrib><creatorcontrib>Vandrey, Ryan G</creatorcontrib><creatorcontrib>Bigelow, George E</creatorcontrib><creatorcontrib>Leoutsakos, Jeannie-Marie</creatorcontrib><creatorcontrib>Stitzer, Maxine L</creatorcontrib><creatorcontrib>Strain, Eric C</creatorcontrib><creatorcontrib>Copersino, Marc L</creatorcontrib><creatorcontrib>Mintzer, Miriam Z</creatorcontrib><title>Cognitive Performance in Methadone Maintenance Patients: Effects of Time Relative to Dosing and Maintenance Dose Level</title><title>Experimental and clinical psychopharmacology</title><addtitle>Exp Clin Psychopharmacol</addtitle><description>Given the long-term nature of methadone maintenance treatment, it is important to assess the extent of cognitive side effects. This study investigated cognitive and psychomotor performance in 51 methadone maintenance patients (MMP) as a function of time since last methadone dose and maintenance dose level. MMP maintained on doses ranging from 40 to 200 mg (mean = 97 mg) completed a battery of psychomotor and cognitive measures across 2 sessions, during peak and trough states, in a double-blind crossover design. Peak sessions were associated with worse performance on measures of sensory processing, psychomotor speed, divided attention, and working memory, compared with trough sessions. The effects of maintenance dose were mixed, with higher dose resulting in worse performance on aspects of attention and working memory, improved performance on executive function, and no effects on several measures. Longer treatment duration was associated with better performance on some measures, but was also associated with increased sensitivity to time since last dose (i.e., worse performance at peak vs. trough) on some measures. The results suggest that cognitive functioning can fluctuate as a function of time since last dose even in MMP who have been maintained on stable doses for an extended time (mean duration in treatment = 4 years), but worsened performance at peak is limited to a subset of functions and may not be clinically significant at these modest levels of behavioral effect. For patients on stable methadone maintenance doses, maintenance at higher doses may not significantly increase the risk of performance impairment.</description><subject>Adult</subject><subject>Cognition - drug effects</subject><subject>Cognition - physiology</subject><subject>Cognitive Ability</subject><subject>Dose-Response Relationship, Drug</subject><subject>Double-Blind Method</subject><subject>Drug Abuse</subject><subject>Drug Dosages</subject><subject>Drug Therapy</subject><subject>Female</subject><subject>Human</subject><subject>Humans</subject><subject>Male</subject><subject>Methadone - administration &amp; dosage</subject><subject>Methadone Maintenance</subject><subject>Middle Aged</subject><subject>Opiate Substitution Treatment - methods</subject><subject>Outpatient</subject><subject>Psychomotor Performance - drug effects</subject><subject>Psychomotor Performance - physiology</subject><subject>Reaction Time - drug effects</subject><subject>Reaction Time - physiology</subject><subject>Side Effects (Drug)</subject><issn>1064-1297</issn><issn>1936-2293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkVtr3DAQhUVpaS4t9BcUQV8KwY2uttWHQtmmTWBDQ0mfxdge7yp4JUfSLuTfV80mIXmaYeabMwcOIR84-8KZbE6BMakbLl6RQ25kXQlh5OvSs1pVXJjmgByldMMYV9KIt-RAKK1aodQh2S3CyrvsdkivMI4hbsD3SJ2nl5jXMASP9BKcz-jvF1eQHfqcvtKzccQ-JxpGeu02SP_gBPc6OdAfITm_ouCHF8dljHSJO5zekTcjTAnfP9Rj8vfn2fXivFr-_nWx-L6sQMk6V43hja6HFkZpuOxYJ2qNmhmtwYgBBxRSma7XzSA7gUrBCEIJaGrd8r5DJo_Jt73uvO02OPTFeoTJztFtIN7ZAM6-3Hi3tquws4op3jJZBD49CMRwu8WU7U3YRl88W64Zl7VRyhTq857qY0gp4vj0gTP7PyH7mFBBPz539AQ-RlKAkz0AM9g53fUQs-snTP02xuLSzmuwQlhZTlr5D5xqm7w</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>Rass, Olga</creator><creator>Kleykamp, Bethea A</creator><creator>Vandrey, Ryan G</creator><creator>Bigelow, George E</creator><creator>Leoutsakos, Jeannie-Marie</creator><creator>Stitzer, Maxine L</creator><creator>Strain, Eric C</creator><creator>Copersino, Marc L</creator><creator>Mintzer, Miriam Z</creator><general>American Psychological Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7RZ</scope><scope>PSYQQ</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6651-7358</orcidid></search><sort><creationdate>20140601</creationdate><title>Cognitive Performance in Methadone Maintenance Patients: Effects of Time Relative to Dosing and Maintenance Dose Level</title><author>Rass, Olga ; Kleykamp, Bethea A ; Vandrey, Ryan G ; Bigelow, George E ; Leoutsakos, Jeannie-Marie ; Stitzer, Maxine L ; Strain, Eric C ; Copersino, Marc L ; Mintzer, Miriam Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a436t-791756d8af3913b0b265e50955a92dede2349bc57d3b2e44afa242a76581cbe03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Cognition - drug effects</topic><topic>Cognition - physiology</topic><topic>Cognitive Ability</topic><topic>Dose-Response Relationship, Drug</topic><topic>Double-Blind Method</topic><topic>Drug Abuse</topic><topic>Drug Dosages</topic><topic>Drug Therapy</topic><topic>Female</topic><topic>Human</topic><topic>Humans</topic><topic>Male</topic><topic>Methadone - administration &amp; dosage</topic><topic>Methadone Maintenance</topic><topic>Middle Aged</topic><topic>Opiate Substitution Treatment - methods</topic><topic>Outpatient</topic><topic>Psychomotor Performance - drug effects</topic><topic>Psychomotor Performance - physiology</topic><topic>Reaction Time - drug effects</topic><topic>Reaction Time - physiology</topic><topic>Side Effects (Drug)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rass, Olga</creatorcontrib><creatorcontrib>Kleykamp, Bethea A</creatorcontrib><creatorcontrib>Vandrey, Ryan G</creatorcontrib><creatorcontrib>Bigelow, George E</creatorcontrib><creatorcontrib>Leoutsakos, Jeannie-Marie</creatorcontrib><creatorcontrib>Stitzer, Maxine L</creatorcontrib><creatorcontrib>Strain, Eric C</creatorcontrib><creatorcontrib>Copersino, Marc L</creatorcontrib><creatorcontrib>Mintzer, Miriam Z</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Access via APA PsycArticles® (ProQuest)</collection><collection>ProQuest One Psychology</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and clinical psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rass, Olga</au><au>Kleykamp, Bethea A</au><au>Vandrey, Ryan G</au><au>Bigelow, George E</au><au>Leoutsakos, Jeannie-Marie</au><au>Stitzer, Maxine L</au><au>Strain, Eric C</au><au>Copersino, Marc L</au><au>Mintzer, Miriam Z</au><au>Evans, Suzette M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive Performance in Methadone Maintenance Patients: Effects of Time Relative to Dosing and Maintenance Dose Level</atitle><jtitle>Experimental and clinical psychopharmacology</jtitle><addtitle>Exp Clin Psychopharmacol</addtitle><date>2014-06-01</date><risdate>2014</risdate><volume>22</volume><issue>3</issue><spage>248</spage><epage>256</epage><pages>248-256</pages><issn>1064-1297</issn><eissn>1936-2293</eissn><abstract>Given the long-term nature of methadone maintenance treatment, it is important to assess the extent of cognitive side effects. This study investigated cognitive and psychomotor performance in 51 methadone maintenance patients (MMP) as a function of time since last methadone dose and maintenance dose level. MMP maintained on doses ranging from 40 to 200 mg (mean = 97 mg) completed a battery of psychomotor and cognitive measures across 2 sessions, during peak and trough states, in a double-blind crossover design. Peak sessions were associated with worse performance on measures of sensory processing, psychomotor speed, divided attention, and working memory, compared with trough sessions. The effects of maintenance dose were mixed, with higher dose resulting in worse performance on aspects of attention and working memory, improved performance on executive function, and no effects on several measures. Longer treatment duration was associated with better performance on some measures, but was also associated with increased sensitivity to time since last dose (i.e., worse performance at peak vs. trough) on some measures. The results suggest that cognitive functioning can fluctuate as a function of time since last dose even in MMP who have been maintained on stable doses for an extended time (mean duration in treatment = 4 years), but worsened performance at peak is limited to a subset of functions and may not be clinically significant at these modest levels of behavioral effect. For patients on stable methadone maintenance doses, maintenance at higher doses may not significantly increase the risk of performance impairment.</abstract><cop>United States</cop><pub>American Psychological Association</pub><pmid>24548244</pmid><doi>10.1037/a0035712</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-6651-7358</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1064-1297
ispartof Experimental and clinical psychopharmacology, 2014-06, Vol.22 (3), p.248-256
issn 1064-1297
1936-2293
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4041803
source MEDLINE; EBSCOhost APA PsycARTICLES
subjects Adult
Cognition - drug effects
Cognition - physiology
Cognitive Ability
Dose-Response Relationship, Drug
Double-Blind Method
Drug Abuse
Drug Dosages
Drug Therapy
Female
Human
Humans
Male
Methadone - administration & dosage
Methadone Maintenance
Middle Aged
Opiate Substitution Treatment - methods
Outpatient
Psychomotor Performance - drug effects
Psychomotor Performance - physiology
Reaction Time - drug effects
Reaction Time - physiology
Side Effects (Drug)
title Cognitive Performance in Methadone Maintenance Patients: Effects of Time Relative to Dosing and Maintenance Dose Level
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A02%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20Performance%20in%20Methadone%20Maintenance%20Patients:%20Effects%20of%20Time%20Relative%20to%20Dosing%20and%20Maintenance%20Dose%20Level&rft.jtitle=Experimental%20and%20clinical%20psychopharmacology&rft.au=Rass,%20Olga&rft.date=2014-06-01&rft.volume=22&rft.issue=3&rft.spage=248&rft.epage=256&rft.pages=248-256&rft.issn=1064-1297&rft.eissn=1936-2293&rft_id=info:doi/10.1037/a0035712&rft_dat=%3Cproquest_pubme%3E1501369449%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1501369449&rft_id=info:pmid/24548244&rfr_iscdi=true